Intermediate-size Patient Population Expanded Access Protocol

Summary

The purpose of this Expanded Access Program is to provide tazbentetol to ALS patients who are not eligible to enroll in an ALS clinical trial. This Expanded Access Program will assess safety and tolerability, and clinical efficacy of tazbentelol.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications